Instructor in Medicine
Oncology
Dr. Jason E. Faris, MD
|
|
Give Review
Jason Faris is an expert in the field of Oncology. He studied medicine at Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is a top medical university. Johns Hopkins University School of Medicine is ranked 3 in research and 29 in primary care medicine Jason Faris is also published. He has 13 publications published. The lastest publication: "Clinical Acquired Resistance to RAF Inhibitor Combinations in BRAF-Mutant Colorectal Cancer through MAPK Pathway Alterations.' Jason Faris is registered with Medicare and accepts Medicare payments.
Publications
- Clinical Acquired Resistance to RAF Inhibitor Combinations in BRAF-Mutant ColoRectal Cancer through MAPK Pathway Alterations.
- Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic Cancer.
- Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder Cancer.
- Mutational Analysis and clinical correlation of metastatic colorectal cancer.
- Circulating oncometabolite 2-hydroxyglutarate is a potential surrogate biomarker in patients with isocitrate dehydrogenase-mutant intrahepatic cholangiocarcinoma.
- Controversy and Consensus on the Management of Patients With Pseudomyxoma Peritonei.
- Trees, Forests, and Other Implications of a BRAF Mutant Gene Signature in Patients With BRAF Wild-Type Disease.
- A phase 2 study of oral MKC-1, an inhibitor of importin-?, tubulin, and the mTOR pathway in patients with unresectable or metastatic pancreatic Cancer.
- Primary mediastinal large B-cell lymphoma.
- Sunitinib (sutent)-induced thyrotoxicosis due to destructive thyroiditis: a case report.
- Time tells the tale.
- The controversial role of chemoradiation for patients with locally advanced pancreatic Cancer.
Schools
Johns Hopkins University School of Medicine
Massachusetts General Hospital
Procedures Preformed
- Thoracentesis
Conditions Treated
- Anal and Rectal Cancer
- Anemia
- Bile Duct Cancer
- Bladder Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
Massachusetts General Hospital -
Johns Hopkins University School of Medicine
Drug Facts
| NPI NUMBER | 1134255813 | |
| NPPES Provider LastName | FARIS | |
| NPPES Provider FirstName | JASON | |
| NPPES Provider ZIPCode | 021142621 | |
| NPPES Provider State | MA | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 103.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1134255813 |
| Last Name Of The Provider | FARIS |
| First Name Of The Provider | JASON |
| View All |
Similar Doctors
|
|
Dr. Richard T. Penson, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Yariv J. Houvras, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Geoffrey Liu, MD |
|
|
Dr. Andrew S. Paulson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tilak K. Sundaresan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gregory J. Britt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rana R. McKay, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jason Luke, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Prudence Lam, MD |
|
|
Dr. Arnold S. Freedman, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|